Literature DB >> 24368594

Direct inhibitors of thrombin and factor Xa: the importance of laboratory skills.

Francesco Marongiu1, Doris Barcellona.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 24368594     DOI: 10.1007/s11739-013-1034-7

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

Review 1.  Cost-effectiveness of therapeutic drug monitoring: a systematic review.

Authors:  D J Touw; C Neef; A H Thomson; A A Vinks
Journal:  Ther Drug Monit       Date:  2005-02       Impact factor: 3.681

2.  Measuring Oral Direct Inhibitors (ODIs) of thrombin and factor Xa: A recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.

Authors:  T Baglin; A Hillarp; A Tripodi; I Elalamy; H Buller; W Ageno
Journal:  J Thromb Haemost       Date:  2013-01-24       Impact factor: 5.824

3.  Laboratory tests during direct oral anticoagulant treatment? No.

Authors:  Giovanni Di Minno; Elena Ricciardi; Antonella Scalera
Journal:  Intern Emerg Med       Date:  2013-05-21       Impact factor: 3.397

4.  Laboratory tests during direct oral anticoagulant treatment? Yes.

Authors:  Vittorio Pengo
Journal:  Intern Emerg Med       Date:  2013-05-21       Impact factor: 3.397

Review 5.  New oral anticoagulants in atrial fibrillation: a reappraisal of trial results looking at absolute figures.

Authors:  Sergio Coccheri; Donatella Orlando
Journal:  Intern Emerg Med       Date:  2012-12-18       Impact factor: 3.397

  5 in total
  2 in total

1.  Laboratory tests during direct oral anticoagulant treatment? Authors' reply.

Authors:  Giovanni Di Minno; Elena Ricciardi; Antonella Scalera
Journal:  Intern Emerg Med       Date:  2015-06-19       Impact factor: 3.397

2.  Direct oral anticoagulants: what can we learn?

Authors:  Francesco Marongiu; Doris Barcellona
Journal:  Intern Emerg Med       Date:  2018-03-02       Impact factor: 3.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.